Do we need biopsies of metastases for colorectal cancer patients?

por Floriani, I, Santini, D, Torri, V, Cremolini, C, Falcone, A, Loupakis, F
Publicado 2009

Role of molecular genetics in the clinical management of cholangiocarcinoma

por Normanno, N., Martinelli, E., Melisi, D., Pinto, C., Rimassa, L., Santini, D., Scarpa, A.
Publicado 2022

Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial

por Vincenzi, B, Santini, D, Rabitti, C, Coppola, R, Beomonte Zobel, B, Trodella, L, Tonini, G
Publicado 2006

Procalcitonin as diagnostic marker of infection in solid tumors patients with fever

por Vincenzi, B., Fioroni, I., Pantano, F., Angeletti, S., Dicuonzo, G., Zoccoli, A., Santini, D., Tonini, G.
Publicado 2016

Cetuximab in small bowel adenocarcinoma: a new friend?

por Santini, D, Fratto, M E, Spoto, C, Russo, A, Galluzzo, S, Zoccoli, A, Vincenzi, B, Tonini, G
Publicado 2010

SO-1 The impact of COVID-19 on daily practice patterns in the third-line setting for patients with metastatic colorectal cancer: Results of a real-world survey

por Prager, G., Köhne, C., O’Connor, J., Rivera Herrero, F., Santini, D., Wasan, H., Phelip, J.
Publicado 2021

Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors

por Lamberti, G., Ceccarelli, C., Brighi, N., Maggio, I., Santini, D., Mosconi, C., Ricci, C., Biasco, G., Campana, D.
Publicado 2017

A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer

por Graziano, F, Santini, D, Testa, E, Catalano, V, Beretta, G D, Mosconi, S, Tonini, G, Lai, V, Labianca, R, Cascinu, S
Publicado 2003

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment(†)

por Santini, D, Armento, G, Giusti, R, Ferrara, M, Moro, C, Fulfaro, F, Bossi, P, Arena, F, Ripamonti, C.I
Publicado 2020

Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment

por Fioramonti, M., Fausti, V., Pantano, F., Iuliani, M., Ribelli, G., Lotti, F., Pignochino, Y., Grignani, G., Santini, D., Tonini, G., Vincenzi, B.
Publicado 2018

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

por Catalano, V, Graziano, F, Santini, D, D'Emidio, S, Baldelli, A M, Rossi, D, Vincenzi, B, Giordani, P, Alessandroni, P, Testa, E, Tonini, G, Catalano, G
Publicado 2008

Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer

por Cursano, M. C., Conteduca, V., Scarpi, E., Gurioli, G., Casadei, C., Gargiulo, S., Altavilla, A., Lolli, C., Vincenzi, B., Tonini, G., Santini, D., De Giorgi, U.
Publicado 2022

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients

por Tonini, G, Vincenzi, B, Santini, D, Scarpa, S, Vasaturo, T, Malacrino, C, Coppola, R, Magistrelli, P, Borzomati, D, Baldi, A, Antinori, A, Caricato, M, Nuzzo, G, Picciocchi, A
Publicado 2005

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients

por Tonini, G, Vincenzi, B, Santini, D, Scarpa, S, Vasaturo, T, Malacrino, C, Coppola, R, Magistrelli, P, Borzomati, D, Baldi, A, Antinori, A, Caricato, M, Nuzzo, G, Picciocchi, A
Publicado 2005

Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline

por Grassi, L., Caruso, R., Riba, M.B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., Ripamonti, C.I.
Publicado 2023

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

por Pantaleo, M. A., Landuzzi, L., Nicoletti, G., Nanni, C., Boschi, S., Piazzi, G., Santini, D., Di Battista, M., Castellucci, P., Lodi, F., Fanti, S., Lollini, P.-L., Biasco, G.
Publicado 2009

Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline

por Stone, P., Buckle, P., Dolan, R., Feliu, J., Hui, D., Laird, B.J.A., Maltoni, M., Moine, S., Morita, T., Nabal, M., Vickerstaff, V., White, N., Santini, D., Ripamonti, C.I.
Publicado 2023

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes

por Perrone, G., Morini, S., Santini, D., Rabitti, C., Vincenzi, B., Alloni, R., Antinori, A., Magistrelli, P., Lai, R., Cass, C., Mackey, J.R., Coppola, R., Tonini, G., Onetti Muda, A.
Publicado 2010

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

por Santini, D, Graziano, F, Catalano, V, Di Seri, M, Testa, E, Baldelli, AM, Giordani, P, La Cesa, A, Spalletta, B, Vincenzi, B, Russo, A, Caraglia, M, Virzi, V, Cascinu, S, Tonini, G
Publicado 2006

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways

por Bruzzese, F, Pucci, B, Milone, M R, Ciardiello, C, Franco, R, Chianese, M I, Rocco, M, Di Gennaro, E, Leone, A, Luciano, A, Arra, C, Santini, D, Caraglia, M, Budillon, A
Publicado 2013